INOGEN, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
INOGEN, INC. (INGN) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-02-27
- INOGEN, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2024-12-31 was $0.00.
- INOGEN, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2024-09-30 was $0.00.
- INOGEN, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2024-06-30 was $0.00.
- INOGEN, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- INOGEN, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- INOGEN, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $735.00K, a 137.86% increase from fiscal 2022.
- INOGEN, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $309.00K, a 97.87% decline from fiscal 2021.
- INOGEN, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2021 was $14.52M, a 2840.08% increase from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $0.00 derived: sum of 2 quarters · filed 2026-02-27 | $0.00 derived: sum of 3 quarters · filed 2026-02-27 | $0.00 10-K · filed 2026-02-27 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $0.00 derived: sum of 2 quarters · filed 2024-11-08 | $0.00 10-Q · filed 2024-11-08 | $0.00 derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $0.00 10-Q · filed 2024-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-02-27 | $0.00 derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-02-27 | $0.00 derived: sum of 3 quarters · filed 2026-02-27 | $0.00 derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $0.00 derived: sum of 2 quarters · filed 2026-02-27 | $0.00 derived: sum of 3 quarters · filed 2026-02-27 | $735.00K 10-K · filed 2026-02-27 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $0.00 derived: sum of 2 quarters · filed 2024-11-08 | $735.00K 10-Q · filed 2024-11-08 | $840.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $735.00K 10-Q · filed 2024-08-07 | $840.00K derived: sum of 3 quarters · filed 2025-02-28 | $840.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $735.00K 10-Q · filed 2024-05-08 | $840.00K derived: sum of 2 quarters · filed 2025-02-28 | $840.00K derived: sum of 3 quarters · filed 2025-02-28 | $960.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $105.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $105.00K derived: sum of 2 quarters · filed 2025-02-28 | $225.00K derived: sum of 3 quarters · filed 2025-02-28 | $309.00K 10-K · filed 2025-02-28 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $120.00K derived: sum of 2 quarters · filed 2023-11-09 | $204.00K 10-Q · filed 2023-11-09 | $204.00K derived: sum of 4 quarters · filed 2024-03-01 |
| 2022-06-30 | $120.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $204.00K 10-Q · filed 2023-08-08 | $204.00K derived: sum of 3 quarters · filed 2024-03-01 | $3.33M derived: sum of 4 quarters · filed 2024-03-01 |
| 2022-03-31 | $84.00K 10-Q · filed 2023-05-05 | $84.00K derived: sum of 2 quarters · filed 2024-03-01 | $3.21M derived: sum of 3 quarters · filed 2024-03-01 | $8.10M derived: sum of 4 quarters · filed 2024-03-01 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $3.12M derived: sum of 2 quarters · filed 2024-03-01 | $8.02M derived: sum of 3 quarters · filed 2024-03-01 | $14.52M 10-K · filed 2024-03-01 |
| 2021-09-30 | $3.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $8.02M derived: sum of 2 quarters · filed 2022-11-03 | $14.52M 10-Q · filed 2022-11-03 | $14.75M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-06-30 | $4.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $11.40M 10-Q · filed 2022-08-04 | $11.63M derived: sum of 3 quarters · filed 2023-02-24 | $11.63M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-03-31 | $6.50M 10-Q · filed 2022-05-05 | $6.73M derived: sum of 2 quarters · filed 2023-02-24 | $6.73M derived: sum of 3 quarters · filed 2023-02-24 | $6.76M derived: sum of 4 quarters · filed 2023-02-24 |
| 2020-12-31 | $225.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $225.00K derived: sum of 2 quarters · filed 2023-02-24 | $255.00K derived: sum of 3 quarters · filed 2023-02-24 | $494.00K 10-K · filed 2023-02-24 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $30.00K derived: sum of 2 quarters · filed 2021-11-04 | $269.00K 10-Q · filed 2021-11-04 | $1.16M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $269.00K 10-Q · filed 2021-08-04 | $1.16M derived: sum of 3 quarters · filed 2022-02-24 | $1.31M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $239.00K 10-Q · filed 2021-05-04 | $1.13M derived: sum of 2 quarters · filed 2022-02-24 | $1.28M derived: sum of 3 quarters · filed 2022-02-24 | $1.42M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $893.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $1.04M derived: sum of 2 quarters · filed 2022-02-24 | $1.18M derived: sum of 3 quarters · filed 2022-02-24 | $7.91M 10-K · filed 2022-02-24 |
| 2019-09-30 | $147.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $284.00K derived: sum of 2 quarters · filed 2020-11-04 | $7.02M 10-Q · filed 2020-11-04 | $40.10M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $137.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $6.87M 10-Q · filed 2020-08-04 | $39.95M derived: sum of 3 quarters · filed 2021-02-24 | $72.66M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $6.73M 10-Q · filed 2020-05-05 | $39.82M derived: sum of 2 quarters · filed 2021-02-24 | $72.52M derived: sum of 3 quarters · filed 2021-02-24 | $89.36M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $33.08M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $65.79M derived: sum of 2 quarters · filed 2021-02-24 | $82.63M derived: sum of 3 quarters · filed 2021-02-24 | $98.74M 10-K · filed 2021-02-24 |
| 2018-09-30 | $32.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $49.55M derived: sum of 2 quarters · filed 2019-11-05 | $65.66M 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $16.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $32.96M 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | $16.11M 10-Q · filed 2019-05-07 | |||
| 2017-12-31 | $33.93M 10-K · filed 2020-02-25 | |||
| 2016-12-31 | $22.23M 10-K · filed 2019-02-26 | |||
| 2014-12-31 | $15.49M 10-K · filed 2015-04-27 | |||
| 2013-12-31 | $30.00K 10-K · filed 2015-04-27 | |||
| 2012-12-31 | $2.00K 10-K · filed 2015-04-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| ENvue Medical, Inc. (FEED) | United States | $0.011B |